Loading company…
Momentum Clinical Research runs clinical trials and research services for pharmaceutical companies, CROs, and researchers.
Founded in 1998 and based in Queensland, Australia, Momentum Clinical Research conducts Phase Ib-IV trials and research for sponsors, CROs, and researchers. Its services include patient recruitment, trial management, ethics approvals, research governance, and GCP compliance. Genesis Capital acquired a 90% stake in December 2022 for USD 8.8 million; P3 Research, AusTrials, and Holdsworth House Medical Group combined to form Momentum Clinical Research in July 2024. As of February 2025, CEO Josh Stent led the company, which also has offices across New Zealand.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in